SNP influencing warfarin dose identified in African Americans

Patients carrying the SNP, which is located in the CYP2C9 gene, require a significantly lower stable dose of warfarin than do those without the variant, say researchers. The addition of the SNP also improved the International Warfarin Pharmacogenetics Consortium treatment algorithm by 21%.
Source: theHeart.org - Category: Cardiology Source Type: news